Zurueck zur Suche

Reporte zur Charge HN5BE

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 4 LA 1 OK 1 MA 1 NV 1 CA 1 MN 1 NH 1

VAERS 2316363

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
11.06.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

received two pediatric doses instead of adult dose; This case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a adult patient who received HBV (Engerix B pediatric) (batch number HN5BE, expiry date unknown) for prophylaxis. Co-suspect products included HBV (Engerix B pediatric) (batch number HN5BE, expiry date unknown) for prophylaxis. On an unknown date, the patient received Engerix B pediatric and Engerix B pediatric. On an unknown date, unknown after receiving Engerix B pediatric and Engerix B pediatric, the patient experienced adult use of a child product. On an unknown date, the outcome of the adult use of a child product was unknown. Additional Information: GSK Receipt Date: 08-JUN-2022 Reporter's comments: The Healthcare Professional was looking for an information on a patient who received two pediatric doses (lot number: HN5BE) with 18 hours of difference instead of an adult dose. The reporter stated that this situation happened a year ago from the day of reporting. The reporter consented to follow up via email. Additional Supportive Information: The patient received 2 doses of Engerix B pediatric instead of Engerix B adult, which led to adult use of a child product.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1869309

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
LA
Alter
0,2
Geschlecht
F
Eingang
15.11.2021
Impfdatum
12.11.2021
Beginn
12.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

Pt given expired dose of Hepititis B vaccine. Pt mother denies any adverse reaction symptoms. Facility administered unexpired Hepititis B vaccine to Pt with mother's consent.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
None reported
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 1787742

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
OK
Alter
13,0
Geschlecht
F
Eingang
15.10.2021
Impfdatum
06.10.2021
Beginn
06.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

vaccinated with expired Engerix-B; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 13-year-old female patient who received HBV (Engerix B) (batch number HN5BE, expiry date 16th September 2021) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th October 2021, the patient received Engerix B .5 ml and Engerix B Pre-Filled Syringe Device. On 6th October 2021, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received expired dose of Engerix B in right deltoid, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1773377

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
TX
Alter
13,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
04.10.2021
Beginn
04.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

received an expired dose; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 13-year-old female patient who received HBV (Engerix B pediatric) (batch number HN5BE, expiry date 16th September 2021) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 4th October 2021, the patient received Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On 4th October 2021, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The patient received an expired dose of ENGERIX-B which led to expired vaccine used. No further events were reported. The consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1766823

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
TX
Alter
-
Geschlecht
F
Eingang
07.10.2021
Impfdatum
29.09.2021
Beginn
29.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

received an expired pediatric ENGERIX-B vaccine; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a female patient who received HBV (Engerix B pediatric) (batch number HN5BE, expiry date 16th September 2021) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 29th September 2021, the patient received Engerix B pediatric 10 mcg .5 ml and Engerix B Pre-Filled Syringe Device. On 29th September 2021, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter was the certified medical assistant called from a doctors office. The age at vaccination was not reported. The reporter stated that, the patient received an expired pediatric Engerix B vaccine, which led to expired vaccine used. The reporter did not have the chart in front of her therefore did not have the patient's date of birth and failed to ask for the patient's initials.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Engerix B Pre-Filled Syringe Device
Allergien
-
Vorherige Impfungen
-

VAERS 1751718

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
TX
Alter
52,0
Geschlecht
F
Eingang
01.10.2021
Impfdatum
27.09.2021
Beginn
27.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

expired dose administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 52-year-old female patient who received HBV (Engerix B) (batch number HN5BE, expiry date 16th September 2021) for prophylaxis. On 27th September 2021, the patient received Engerix B. On 27th September 2021, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional details were provided as follows: The nurse reported that female patient received expired dose of Engerix-B, which led to expired vaccine used. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1741188

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
TX
Alter
52,0
Geschlecht
F
Eingang
28.09.2021
Impfdatum
27.09.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Unevaluable event

Symptomtext

n/a

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
nka
Vorherige Impfungen
-

VAERS 1730701

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
MA
Alter
-
Geschlecht
F
Eingang
24.09.2021
Impfdatum
17.09.2021
Beginn
17.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired vaccine administered; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a female patient who received HBV (Engerix B) (batch number HN5BE, expiry date 16th September 2021) for prophylaxis. On 17th September 2021, the patient received Engerix B 10 ug. On 17th September 2021, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional details were provided as follows: The age at vaccination was not reported. The patient received expired Engerix-B 10 microgram vaccine, the vaccine was expired on 16th September 2021, which led to expired vaccine used. The pharmacist was not allowed to provide patient?s details The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1666444

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
NV
Alter
9,0
Geschlecht
F
Eingang
02.09.2021
Impfdatum
01.09.2021
Beginn
01.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Adult Hepatitis A vaccine was given to a 9 year old pediatric patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1306302

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
11.05.2021
Impfdatum
06.05.2021
Beginn
06.05.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Underdose

Symptomtext

pediatric dose/to a male adult patient.; pediatric dose/to a male adult patient.; This case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 64-year-old male patient who received HBV (Engerix B pediatric) (batch number HN5BE, expiry date 16th September 2021) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th May 2021, the patient received the 1st dose of Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On 6th May 2021, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced adult use of a child product and underdose. On an unknown date, the outcome of the adult use of a child product and underdose were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The age at vaccination was not reported. The reporter called to report that a medical assistant of the center where she works, applied a pediatric dose of Engerix-B vaccine to adult patient, which led to adult use of a child product and underdose. At the time of the reporting, the patient was doing well. No further details were reported. The reporter consented to follow up by email.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1033110

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge HN5BE

gering
Staat
MN
Alter
2,0
Geschlecht
F
Eingang
16.02.2021
Impfdatum
16.02.2021
Beginn
16.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

2 doses of Hep B given at visit on 2-16-2021, 1 dose of Energix-B by GSK and 1 dose of Pediarix by GSK.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 974561

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge hn5be

gering
Staat
NH
Alter
-
Geschlecht
M
Eingang
26.01.2021
Impfdatum
17.08.2019
Beginn
19.08.2019
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LG
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspepsia Infantile back arching Petit mal epilepsy Strabismus

Symptomtext

Arching of the back that lasted for weeks after the 19th. The lining of his eyes was off - strabismus that resolved itself months after the vaccine. Silent seizures, problems with digestion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspepsia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Not known
Vorgeschichte
Not known
Andere Medikamente
No
Allergien
Not known
Vorherige Impfungen
-